Search

Search Constraints

You searched for: Author/Creator Río, Jordi

Search Results

3. Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis. (27th September 2016)

4. COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response. (9th January 2021)

5. Disability progression markers over 6–12 years in interferon-β-treated multiple sclerosis patients. (March 2018)

6. Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated Syndrome. (26th October 2021)

7. Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated Syndrome. (26th October 2021)

8. Evaluating the response to glatiramer acetate in relapsing–remitting multiple sclerosis (RRMS) patients. (October 2014)

10. HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis. Issue 6 (19th April 2014)